title: Brief commentary: largest randomized trial of biliary tract cancer treatment with cisplatin plus gemcitabine versus gemcitabine alone: an excellent opportunity to evaluate the prognostic value of tumor marker CA 19-9.
authors: M Sitki
authors: MS
authors: Copur
authors: Angela
authors: A
authors: Obermiller